Application | Comment | Organism |
---|---|---|
medicine | metabolic enzyme sucrase-isomaltase is one of the most frequently mutated genes in a cohort of 105 chronic lymphocytic leukemia patients. Mutations result in loss of enzyme function by preventing the biosynthesis of catalytically competent sucrase-isomaltase at the cell surface. Mutations impair enzyme function by altering its trafficking along the secretory pathway. Loss-of-function mutations in sucrase-isomaltase result in gene expression patterns that depict ample metabolic reprogramming, pinpointing sucrase-isomaltase as a putative player in the cancer-associated metabolic switch | Homo sapiens |
Protein Variants | Comment | Organism |
---|---|---|
D1193N | mutation identified in chronic lymphocytic leukemia patient. Mutation is located in the C-terminal sucrase domain and results in a 25% decrease in activity and decrease of complex glycosylated forms of the mature enzyme | Homo sapiens |
R91T | mutation identified in chronic lymphocytic leukemia patient. Mutation is inserted in a trefoil motif situated N-terminal to the isomaltase domain and results in a 75% decrease in activity and decrease of complex glycosylated forms of the mature enzyme | Homo sapiens |
T1680I | mutation identified in chronic lymphocytic leukemia patient. Mutation is located in the C-terminal sucrase domain, leads to decrease of complex glycosylated forms of the mature enzyme | Homo sapiens |
W1493C | mutation identified in chronic lymphocytic leukemia patient. Mutation is located in the C-terminal sucrase domain with almost complete loss of activity and decrease of complex glycosylated forms of the mature enzyme | Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | P14410 | - |
- |